Meprobamate Tablet
Product Images NDC 69097-975

3 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meprobamate (NDC 69097-975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure diagram of meprobamate, showing its molecular arrangement with amino, carbamate, and other functional groups represented.*
FDA Label Image

200mg Label. (200mg Label)

200mg Label. (200mg Label)
Label for Meprobamate Tablets USP 200 mg oral tablets by Cipla USA Inc. The label indicates each tablet contains 200 mg of Meprobamate. It is a prescription drug with a schedule IV designation. The package contains 100 tablets. Storage instructions and manufacturing details by InvaGen Pharmaceuticals and Cipla USA, Inc. are included along with a barcode and a QR code.*
FDA Label Image

400mg Label. (400mg Label)

400mg Label. (400mg Label)
Meprobamate Tablets USP 400 mg oral tablets packaging label by Cipla USA Inc. The label indicates the product contains 100 tablets. It includes dosage and storage instructions, manufacturer information (InvaGen Pharmaceuticals, a Cipla subsidiary), and barcodes for scanning. The label design uses black text on a white background with a green highlight for the strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.